International Research Journal of Oncology

Metastasis in Cancer and Tumor Cells

Ikalo David Oseghale *

Department of Biochemistry, Faculty of life Sciences, University of Benin, Nigeria.

Godwin Mmaduabuchi Ikokwu

Faculty of Pharmacy, University of Benin, Nigeria.

Uyinonijesu Diamond Victor-Ogie

Faculty of Pharmacy, University of Benin, Nigeria.

*Author to whom correspondence should be addressed.

---

Abstract

A crucial stage in the development of cancer is metastasis, which greatly increases patient morbidity and mortality. The process of metastasis involves several steps, starting with the local invasion of cancer cells into the surrounding tissues, then extravasation, colonization at distant sites, survival in the bloodstream, and intravasation. Changes in cell adhesion, modification of the extracellular matrix, migration, invasion, immune evasion, angiogenesis, and the creation of a favorable microenvironment are only a few of the molecular and cellular processes that cause metastasis. Tumor heterogeneity, interactions with the tumor microenvironment, genetic and epigenetic variables, and immunological reactions all have an impact on the process. As a prognostic signal and a barrier to early discovery and efficient treatment, metastasis has significant clinical ramifications. Promising targeted treatments to prevent metastasis include those that target important signaling pathways, immune checkpoint blocking, and anti-angiogenic drugs. New approaches that target cancer stem cells, the tumor microenvironment, and the use of nanoparticles for targeted medication delivery are also being investigated. Even with breakthroughs, there are still many elements of metastasis that are unclear, highlighting the need for more study to understand its complexities, find new therapeutic targets, and provide individualized therapies to prevent or treat metastatic cancer. For bettering cancer patient outcomes and easing the burden of this terrible disease, it is essential to comprehend metastasis and effectively address it.

Keywords: Metastasis, cancer, tumor, cells, immunology

---

---

---

References

Fares J, Fares MY, Khachfe HH. et al. Molecular principles of metastasis: A hallmark of cancer revisited. Sig Transduct Target Ther. 2020;5:28. Available:https://doi.org/10.1038/s41392-020-0134-x

Chukwurah I, Oseghale ID, Ikokwu GM, Ezeokoli CA. A brief review of tumor immunology. International Research Journal of Oncology. 2023;7(2):1-12.

Liu J, Luo F, Wen L, Zhao Z, Sun H. Current understanding of microbiomes in cancer metastasis. Cancers. 2023;15:1893. Available:https://doi.org/10.3390/ cancers15061893

Oseghale ID, Omoregie I, Ikokwu GM. Molecular imaging for early cancer diagnosis. International Research Journal of Oncology. 2023;7(1):1-8.

Welch DR, Hurst DR. Defining the hallmarks of metastasis. Cancer Res. 2019;79(12):3011-3027.

DOI: 10.1158/0008-5472.CAN-19-0458 Epub 2019 May 3. PMID: 31053634; PMCID: PMC6571042

Van Zijl F, Krupitza G, Mikulits W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res. 2011;728(1-2):23-34. DOI: 10.1016/j.mrrev.2011.05.002 Epub 2011 May 12

PMID: 21605699; PMCID: PMC4028085

Pęczek P, Gajda M, Rutkowski K, Fudalej M, Deptała A, Badowska-Kozakiewicz AM. Cancer-associated inflammation: pathophysiology and clinical significance. Journal of cancer research and clinical oncology. 2023;149(6):2657-72.

Meng C, Bai C, Brown TD, Hood LE, Tian Q. Human gut microbiota and gastrointestinal cancer. Genomics, proteomics & bioinformatics. 2018;16(1): 33-49.

Rossi T, Vergara D, Fanini F, Maffia M, Bravaccini S, Pirini F. Microbiota-derived metabolites in tumor progression and metastasis. International Journal of Molecular Sciences. 2020;21(16):5786.

Manfioletti G, Fedele M. Epithelial-Mesenchymal Transition (EMT) 2021. Int. J. Mol. Sci. 2022;23:5848.

Lu W, Kang Y. Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev. Cell. 2019;49:361–374.

Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat. Commun. 2020;11 3259.

Sakamoto Y, Mima K, Ishimoto T, Ogata Y, Imai K, et al. Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis. Cancer Sci. 2021;112:4470–4477.

Ma J, Gnanasekar A, Lee A, Li W.T, Haas M, et al. Influence of intratumor microbiome on clinical outcome and immune processes in prostate cancer. Cancers. 2020;12:2524. [PubMed]

Ma X, Zhou Z, Zhang X, Fan M, Hong Y, et al. Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice. Cell Biol. Toxicol. 2020;36:509–515.

Fu A, Yao B, Dong T, Chen Y, Yao J, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185:1356–1372.e26. [PubMed]

Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview. Eur. J. Med. Chem. 2020; 194:112260.

Niland S, Riscanevo AX, Eble JA. Matrix Metalloproteinases shape the tumor microenvironment in cancer progression. Int. J. Mol. Sci. 2021;23:146.

Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet. 20078(4):286-98. DOI: 10.1038/nrg2005 Epub 2007 Mar 6 PMID: 17339880

Gao et al. Change of urinary cadmium and renal tubular protein in female works after cessation of cadmium exposure: Response to the Letter to the Editor by Kawada (2016). Int Arch Occup Environ Health. 2017;90(3):307.

DOI: 10.1007/s00420-017-1194-2 Epub 2017 Jan 12 PMID: 28083706

Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582-98.

DOI: 10.1038/nrc.2016.73 PMID: 27550820

Fridman WH, Dieu-Nosjean MC, Pagès F, Cremer I, Damotte D, Sautès-Fridman C, Galon J. The immune microenvironment of human tumors: General significance and clinical impact. Cancer Microenviron. 2013;6(2):117-22. DOI: 10.1007/s12307-012-0124-9 Epub 2012 Oct 30

PMID: 23108700; PMCID: PMC3717061